| Stem definition | Drug id | CAS RN |
|---|---|---|
| 491 | 69-81-8 |
None
None
None
None
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Oesophagitis | 70.09 | 48.67 | 15 | 129 | 13246 | 34943541 |
| MedDRA adverse event term | Likelihood ratio | Likelihood ratio threshold | Patients taking drug having adverse event | Patients taking drug not having adverse event | Patients not taking drug having adverse event | Patients not taking drug not having adverse event |
|---|---|---|---|---|---|---|
| Oesophagitis | 61.24 | 31.02 | 15 | 300 | 24274 | 79719799 |
None
| Source | Code | Description |
|---|---|---|
| ATC | B02BX02 | BLOOD AND BLOOD FORMING ORGANS ANTIHEMORRHAGICS VITAMIN K AND OTHER HEMOSTATICS Other systemic hemostatics |
| MeSH PA | D003029 | Coagulants |
| MeSH PA | D006401 | Hematologic Agents |
| MeSH PA | D006490 | Hemostatics |
None
None
None
| Dissociation level | Dissociation constant | Type (acidic/basic) |
|---|---|---|
| pKa1 | 10.86 | acidic |
| pKa2 | 2.34 | Basic |
| pKa3 | 1.41 | Basic |
None
None
None
| ID | Source |
|---|---|
| D01864 | KEGG_DRUG |
| 2011 | RXNORM |
| C0006972 | UMLSCUI |
| CHEBI:31349 | CHEBI |
| CHEMBL2051960 | ChEMBL_ID |
| DB09012 | DRUGBANK_ID |
| C073338 | MESH_SUPPLEMENTAL_RECORD_UI |
| 2557 | PUBCHEM_CID |
| 210 | INN_ID |
| 13051-01-9 | SECONDARY_CAS_RN |
| 81F061RQS4 | UNII |
| 703411008 | SNOMEDCT_US |
| 704671001 | SNOMEDCT_US |
| 90342008 | SNOMEDCT_US |
| 263 | INN_ID |
| 002094 | NDDF |
| 004780 | NDDF |
| Product | Category | Ingredients | NDC | Form | Quantity | Route | Marketing | Label |
|---|---|---|---|---|---|---|---|---|
| IGATAN F | HUMAN OTC DRUG LABEL | 3 | 72689-0027 | CAPSULE | 2 mg | ORAL | unapproved drug other | 7 sections |